Clinical Trial Update: ACT1ON Phase 2 (SMART Pilot) and Phase 3 (Efficacy Trial Development) [NA]

View source ↗

Summary

Clinical trials ACT1ON Phase 2 and Phase 3 have completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Diabetes Mellitus, Type 1, Overweight and Obesity | NA | Status: COMPLETED | Results posted: 2022-03-04